Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Steve Lokness who wrote (3092)	10/29/2010 7:22:42 PM
From: Jibacoa	Respond to of 3722

Steve, RIGL has been on a trending pattern since late July. The support and resistance points to watch are the $7.80 and $8.85, respectively. <g> It has been trimming its loss for the last 4Qs and if the estimates turn out correct, the pending two Qs should provide a positive comparison, since the loss last Yr, was $2.70 and according to data on IBD, which uses numbers from Thomson-Reuters, it is expected to finish on the black this Yr, although to be on the red again with a loss around $1.50 in 2011 <g> On IBD it appears to have a negative CF around $2.10 but on YHOO it appears with nice +CF and +FCF. <g> Both show it with negligible LTD As you are probably aware, the CEO will be presenting at Oppenheimers meeting on Wednesday in NY and the following Thursday at UBS Annual Health Care in Phoenix. Will see if that will help the stock go through its resistance. At my age, I rather wait than try to anticipate what will happen.<g> The ACTAY is $12.80 which would be a good % gain from present levels. <g> On the daily chart, the price is below the EMA10, EMA20 & EMA50, which are all pretty close to one another. <g> stockcharts.com On the weekly chart, it looks better as the price is at the EMA 10, but above the EMA20 and EMA50.<g> stockcharts.com I think that most likely it will be moving up. <g> RAGL Bernard